Oral Contraceptive Rx-to-OTC Switch On The Cusp In UK

The MHRA is consulting on two Rx-to-OTC switch applications for progestogen-only contraceptive pills containing desogestrel, one from HRA Pharma and one from Maxwellia. The move has been welcomed by UK consumer healthcare industry association, the PAGB, as well as the British Pregnancy Advisory Service. 

ContraceptivePill
• Source: Shutterstock

Women in the UK could soon have access to the oral contraceptive pill without a prescription for the first time.

The UK Medicines and Healthcare products Regulatory Agency has launched a public consultation on the Rx-to-OTC reclassification of two progestogen-only...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

Get To Know: Healthy Aging Specialist Prime Fifty

 
• By 

Established by Max Gowland in 2013, Prime Fifty was founded to address the specific nutritional needs of the over 50s.

Haleon Adds High Strength Vitamin D To UK Centrum Multivitamin Line

 
• By 

Centrum Vitamin D Boost combines a wide range of daily vitamins with a 30-microgram dose of vitamin D, delivering six times more of the micronutrient than the firm’s Centrum Advance.

Self-Testing Kits Need To Be Regulated Like OTCs, UK Researchers Argue

 
• By 

Concerns raised by two recent studies prompt UK researchers to argue for greater regulation with regards to direct-to-consumer test kits.

Over The Counter: Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland

 
• By 

HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.

More from Europe

Over The Counter: Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland

 
• By 

HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.

EU Green Claims Directive: Commission Says It ‘Has Not Withdrawn’ From Negotiations

 
• By 

What's going on with the EU Green Claims Directive? HBW Insight speaks to the European Commission, Parliament and Council to find out why trilogue negotiations seem to have stalled.

German Switch Committee Supports OTC Melatonin And Acyclovir, Rejects Rupatadine

 
• By 

Germany’s Expert Committee for Prescription supports the Rx-to-OTC switches of melatonin and buccal acyclovir but rejects rupatadine.